Diabetes mellitus a hypertenzia – letálne duo
Čo rezonuje z tohoročných odporúčaní ESC a kongresu ESC?

Česká verzia

Authors: Andrej Dukát ¹; Slavomíra Filipová ²; Peter Gavorník ¹; Martin Čaprnda ¹; Lucia Mistríková ³; David Baláž ¹; Ľudovít Gašpar ¹
Authors place of work: II. interná klinika LF UK a Univerzitnej nemocnice Bratislava ¹; Národný ústav srdcových chorôb, Bratislava ²; Východoslovenský ústav srdcových chorôb, Košice ³
Published in the journal: Forum Diab 2012; 1(2-3): 86-91
Category: Topic

Summary

Last decades are characterized by pandemic of diabesity and subsequent cardiovascular morbidity and mortality. This extremely severe problem of populations all over the world all the time increases. Diabetes mellitus and hypertension represent duo, which represents which the largest proportion contribute to the extremely high cardiovascular mortality and therefore it is often proclaimed as lethal duo. Hypertension and as well as diabetes mellitus alone represents diseases with increased risk of cardiovascular diseases. The presence of both conditions increases risk 2–4 times and are continuous variable. In this summary authors deal with the important problems these two comorbidities, from the viewpoint of the recent guidelines and congress of ESC.

Key words:
diabetes mellitus – arterial hypertension – epidemiology – therapy

Zdroje

1. Guidelines on diabetes, prediabetes, and cardiovascular diseases. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007. Dostupné z WWW (DOI): http:/doi:10.1093/eur-heartj/ehj261

2. Izzo JL, Sica DA, Black HR (eds). Wolters Kluwer Hypertension Primer. The Essentials of High Blood Pressure. Dallas (Texas): Lippincott Williams Wilkins 2008.

3. European Guidelines on cardiovascular disease prevention in clinical practice 2012. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine socie-ties and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J 2012. Dostupné z WWW (DOI): http:/doi:10.1093/ eurheartj/ehs092

4. European Guidelines on cardiovascular disease prevention in clinical practice 2012. The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovas-cular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur Heart J 2012. Dostupné z WWW (DOI): http:/doi:10:1093/eur-heartj/ehs165

5. Scientific programme: European Congress of Cardiology 2012. Munich 27–31 Aug.2012.

6. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J (eds). Harrison´s Principles of Internal Medicine. 18th Ed. New York: McGraw Hill 2012.